Filing Flows

Filing Flows › Progyny (PGNY) › Q1 2025

Progyny (PGNY) Q1 2025 earnings results (first quarter 2025)

10-Q filed May 9, 2025

Progyny (PGNY) reported revenue of $324M for the first quarter 2025 (Q1 2025), +17% from a year earlier and +9% from the quarter before. Operating margin was 7.5%, net earnings $15.1M (4.6% of revenue).

Revenue$324M
Year over year+17%
Quarter over quarter+9%
Operating margin7.5%
Net earnings$15.1M

Progyny, Q1 2025: revenue $324M (+16% year over year), operating margin 7.5%, net earnings $15.1M, operating cash flow $49.8M. The chart follows the revenue to costs, profit and cash.

Q1 2025AmountQ/QY/Y
Revenue$324M+9%+17%
Gross profit$75.8M+19%+21%
Operating profit$24.2M+53%+30%
Net earnings$15.1M+43%-11%
Operating cash flow$49.8M-5%+94%
Free cash flow$47.0M-7%+89%

What changed

Revenue was $324.0M in Q1 2025, up 17% year over year and up 9% from the previous quarter. Fertility benefits services revenue was the largest line at 64% of revenue. Fertility benefits services revenue added $36.6M year over year (up 22%), 80% of the total change.

Gross margin was 23.4%, up 0.9 points from a year earlier. Operating profit was $24.2M, a 7.5% margin (up 0.8 points year over year). Of the extra revenue versus a year earlier, 12% reached operating profit, above the 7% margin then. Operating expenses grew 18% against revenue growth of 17%. Net earnings were $15.1M, down 11% year over year. The effective tax rate was 43.3%.

Operating cash flow was $49.8M (up 94% year over year), 331% of net earnings. Non-cash charges added back $1.1M of depreciation and amortization and $32.5M of share-based compensation. Capital expenditures of $2.8M left free cash flow of $47.0M.

Questions

What was Progyny's revenue in the first quarter 2025?

Progyny (PGNY) reported revenue of $324M for the first quarter 2025 (Q1 2025), +17% from a year earlier and +9% from the quarter before.

Was Progyny profitable in the first quarter 2025?

Operating profit was $24.2M (7.5% of revenue) and net earnings $15.1M.

Open the interactive Sankey →

Source: Progyny 10-Q on SEC EDGAR.